000 01518 a2200409 4500
005 20250518094652.0
264 0 _c20200820
008 202008s 0 0 eng d
022 _a1096-0333
024 7 _a10.1016/j.taap.2020.114998
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Xiang
245 0 0 _aCasticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p.
_h[electronic resource]
260 _bToxicology and applied pharmacology
_c06 2020
300 _a114998 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBlotting, Western
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aDNA (Cytosine-5-)-Methyltransferase 1
_xdrug effects
650 0 4 _aFlavonoids
_xpharmacology
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMicroRNAs
_xdrug effects
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
700 1 _aWang, Lianghou
700 1 _aCao, Xiaocheng
700 1 _aZhou, Lingli
700 1 _aXu, Chang
700 1 _aCui, Yinghong
700 1 _aQiu, Yebei
700 1 _aCao, Jianguo
773 0 _tToxicology and applied pharmacology
_gvol. 396
_gp. 114998
856 4 0 _uhttps://doi.org/10.1016/j.taap.2020.114998
_zAvailable from publisher's website
999 _c30835489
_d30835489